Atlas Trials

The Potential Protective Role of Venlafaxine Versus Memantine in Paclitaxel Induced Peripheral Neuropathy

Clinical trial NCT04737967 · UNKNOWN

Trial details

NCT number
NCT04737967
Sponsor
Mendel AI
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Oncology PainChemotherapy-induced Peripheral Neuropathy
Start date
2021-02-15
Primary completion
2021-08-15
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.